Dr. Jeffrey J. Kirshner is awarded fellowship designation from the American Society of Clinical Oncology
Hematology-Oncology Associates of CNY, founded in 1982, has announced one of its founding partners and principal investigators for its clinical research department, physician Jeffrey J. Kirshner, will be honored by receiving the prominent distinction of fellow of the American Society of Clinical Oncology (ASCO) at its annual meeting in June.
Over 300 fellowships have been awarded over the years. Kirshner is the first physician in Central New York to earn the designation.
Kirshner serves on ASCO expert panels and committees to provide guidelines for the management of cancer patients used by oncologists around the world.
The Fellow of the American Society of Clinical Oncology (FASCO) distinction recognizes members for their extraordinary volunteer service, dedication and commitment to ASCO. Recipients have carried out efforts that benefit ASCO, the specialty of oncology, and most importantly, the patients whom they serve.
Once conferred, the fellow status is a lifetime recognition. The award was launched in 2007 and was formerly called the ASCO Statesman Award. This distinction honors members for their extraordinary volunteer service and dedication to the American Society of Clinical Oncology and the Association for Clinical Oncology (collectively ASCO). The award was designed to honor ASCO’s most active and valuable members.
Hematology-Oncology Associates has maintained a robust clinical research department for over 35 years.
For more information about HOA’s clinical research department, call 315-472-7504 or visit them on the web at www.hoacny.com.
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 45,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals.
For information about ASCO, visit www.asco.org.